Coastal Investment Advisors, Inc. Esperion Therapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$27.44 - $73.84 $20,580 - $55,380	-750 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$35.4 - $59.82 $2,655 - $4,486	-75 Reduced 9.09%	750 $38,000
Q2 2019 Aug 01, 2019	BUY	$40.1 - $52.33 $10,025 - $13,082	250 Added 43.48%	825 $38,000
Q1 2019 May 15, 2019	BUY	$40.11 - $53.57 $23,063 - $30,802	575 New	575 $23,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.